| Article

An Annals of Internal Medicine online article seeks “To characterize the quality of safety and efficacy data in new drug applications (NDAs) for opioid analgesics approved by the FDA between 1997 and 2018.” Researchers state that “Approvals of prescription opioids by the U.S. Food and Drug...

| Article

Opioids are powerful analgesics, but unfortunately that pain relief may come with side-effects that place a heavy burden on patients. Patients may experience diminished quality of life due to opioid-induced constipation, leading to depression/anxiety, embarrassment, increased cost of healthcare...

| Article

In a guide for team physicians working with young athletes—10 to 18 years old—it is recommended that practitioners look at all factors involved before potentially prescribing opioids to this age group. This Special Communications: Team Physician and Consensus Statement appears in the journal Medicin...

| Podcast

Opioid use and addiction have soared in the United States over the past 20 years, and drug overdoses have become the leading cause of injury death.

Persons with opioid use disorder (OUD), particularly those injecting opioids, frequently require hospitalization and encounter need of acute opioid...

| Article

A poster abstract (LB008) presented at the American Academy of Pain Medicine 36th Annual Meeting acknowledges the potential of sweat as a biofluid alternative for drug testing. The abstract states that, although used extensively, “sampling of urine is inconvenient, tamper prone, and results are...

| Article

The American Medical Association just released a new OPIOID TASK FORCE 2020 PROGRESS REPORT in the hopes of reducing drug overdoses and deaths. Although prescription opioid overdose deaths have decreased, illicit drugs such as heroin, methamphetamine, and cocaine have risen. Last year, fentanyl...

| Article

“Even during this global pandemic, we have continued to prioritize addressing the opioid crisis,” says Stephen M. Hahn, MD, the FDA’s Commissioner, referring to the FDA’s new labeling requirement. This labeling—on opioid pain medication and opioid use disorder medication—must include the...

| Article

According to the CDC, osteoarthritis (OA) affects over 32.5 million US adults. Patients with this chronic pain condition are often prescribed opioids, but with what efficacy? A recent study of patients with knee and/or hip OA examined the differences between strong and weak or intermediate opioids...

| Article

From the Mental Health Clinician journal.

Abstract

Introduction: Chronic lower back pain is a leading cause of disability in US adults. Opioid use continues to be controversial despite the Centers for Disease Control and Prevention guidance on chronic pain management to use nonpharmacologic...

| Article

From the AAPM 36th Annual Meeting Scientific Poster Abstracts: 205. Coauthored by Senior PAINWeek Faculty Dr. Kevin Zacharoff.

Many physicians report inadequate training in the areas of pain assessment, treatment, and aberrant drug-related behaviors. This presentation will describe the...

Subscribe to opioids

Sign-Up